Amlozaar H (Amlodipine/Losartan/HCTZ) in Kenya

Overview

Amlozaar H is a fixed-dose combination containing amlodipine 5mg (calcium channel blocker), losartan 50mg (angiotensin II receptor antagonist), and hydrochlorothiazide 12.5mg (thiazide diuretic). It treats hypertension (high blood pressure) by relaxing blood vessels, reducing fluid retention, and blocking hormones that constrict vessels. This triple-action therapy is used when single or dual therapy fails. Available as film-coated tablets in Kenya, it requires prescription and monitoring.

Composition

Side Effects

Common

• Dizziness/Headache: Due to BP reduction (amlodipine/HCTZ).
• Electrolyte Imbalances: Hypokalemia (low potassium), hyponatremia (low sodium).
• Muscle Cramps: From HCTZ-induced electrolyte loss.
• Fatigue, Flushing: Amlodipine-related.

Serious Risks

• Hypotension: Severe BP drop (risk in volume-depleted patients).
• Renal Impairment: Worsening kidney function (monitor creatinine).
• Hyperuricemia: Elevated uric acid (gout risk).
• Hyperglycemia: HCTZ may raise blood sugar (monitor in diabetics).
• Angioedema: Facial/throat swelling (losartan-related; emergency).

ow to Use

• Dosage:
  • Starting: 1 tablet once daily.
  • Max Dose: 1 tablet daily (higher strengths available if needed).
• Administration:
  • Take in the morning to avoid nocturia (HCTZ effect).
  • With or without food.
• Monitoring:
  • Blood Pressure: Check every 2–4 weeks until stable.
  • Electrolytes: Potassium, sodium, creatinine at baseline, then every 3–6 months.
  • Renal Function: eGFR every 6 months.
• Precautions:
  • Avoid if: Severe renal impairment (eGFR <30 mL/min), pregnancy, sulfa allergy (HCTZ).
  • Drug Interactions:
    • NSAIDs (e.g., ibuprofen): Reduce efficacy and increase renal risk.
    • Potassium Supplements/ACE Inhibitors: Increase hyperkalemia risk.
    • Lithium: Increased lithium toxicity.

Frequently Asked Questions

1. Is Amlozaar H available over-the-counter in Kenya?
   No – prescription-only by physicians.

2. How much does it cost?
   ~KES 1,500–3,000 per pack (28 tablets). Generics cost KES 800–1,500.

3. Does NHIF cover it?
   Partially – covered for hypertension under chronic illness scheme (co-payment required).

4. Can it be used for heart failure?
   Off-label – sometimes used but not first-line (prefer ACE-I/ARB + beta-blocker).

5. What if potassium levels drop?
   Stop immediately and consult a doctor; may need potassium supplements.

6. Are there cheaper alternatives?
   Yes – separate amlodipine + losartan + HCTZ costs 20–30% less.

7. Is it safe during pregnancy?
   No – losartan/HCTZ are teratogenic; use methyldopa instead.

8. How long does one pack last?
   28 days (1 tablet/day).

Conclusion

Amlozaar H is a convenient, triple-therapy option for treatment-resistant hypertension in Kenya, combining amlodipine’s vasodilation, losartan’s RAAS blockade, and HCTZ’s diuretic effect. While cost-effective and partially NHIF-covered, it demands rigorous electrolyte/renal monitoring. Key advantages include once-daily dosing and improved adherence, but side effects like hypokalemia and hyperuricemia require vigilance. For uncomplicated hypertension, lower-cost alternatives (e.g., amlodipine + lisinopril) may suffice, but Amlozaar H offers a streamlined solution for complex cases. Always prioritize lifestyle modifications (low-salt diet, exercise) and regular lab checks to minimize risks. In Kenya’s high-hypertension-prevalence setting, this combination addresses multiple pathways but must be used judiciously to avoid complications.